The seizures market was valued at USD 5.40 Billion in 2025, driven by the increasing prevalence of seizure disorders across the 8 major markets. The market is expected to grow at a CAGR of 4.42% during the forecast period of 2026-2035, with the values likely to reach USD 8.32 Billion by 2035.
Base Year
Historical Period
Forecast Period
The increasing incidence of epilepsy and other seizure disorders is a primary driver of the market, propelling the demand for effective treatments.
The rising introduction of generic antiepileptic drugs and the surge in novel drug approvals from regulatory bodies are significant market trends.
The advancements in diagnostic technologies and the growing focus on non-pharmacological treatments such as neurostimulation devices are set to elevate the market value in the coming years.
Compound Annual Growth Rate
4.42%
Value in USD Billion
2026-2035
*this image is indicative*
A seizure is characterized by a sudden and uncontrolled burst of electrical activity in the brain, causing the change in movements, levels of consciousness, behavior, and feelings. They typically last from 30 seconds to 2 minutes. The types of seizures vary depending on where they originate in the brain and how far they spread. The rising incidence of epilepsy and other seizure disorders is a primary driver of the market, propelling the demand for effective treatments. The market benefits from the increased research and innovation in the field of neurology and the rising introduction of targeted therapies and biologics. Additionally, advancements in diagnostic technologies, rising healthcare expenditure, and the growing demand for precision medicine are anticipated to impact the market dynamics.
Increasing Prevalence of Seizure Disorders is Driving Market Growth
According to the World Health Organisation (WHO), epilepsy ranks as one of the most common neurological diseases and affects about 50 million individuals globally. It is estimated that nearly 50 million individuals suffering from epilepsy are living in low- and middle-income countries, reflecting the need for affordable and effective anti-epileptics. Moreover, recent data suggests that around 10% of individuals have one seizure in their lifetime. The increasing number of cases of epilepsy and other seizure disorders is expected to drive market growth in the coming years.
The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:
Seizures Market Report and Forecast 2026-2035 offers a detailed analysis of the market based on the following segments:
Market Breakup by Drug Type
Market Breakup by Route of Administration
Market Breakup by End User
Market Breakup by Distribution Channel
Market Breakup by Region
The Drug Type Segment Represents a Significant Market Share
The market segmentation by drug type includes first-generation, second-generation, and third-generation anti-epileptic drugs. The first-generation anti-epileptics segment comprises initial treatments that were developed for the treatment of seizures and epilepsy. These drugs such as Phenobarbital and Carbamazepine (Tegretol) are generally less expensive and widely prescribed in low- and middle-income regions. On the other hand, third-generation anti-epileptics include the newest class of seizure treatment that has reduced side effects, improved efficacy, and less frequent dosing.
The market segmentation by region includes the United States, EU-4 (Germany, France, Italy, Spain), and the United Kingdom, Japan, and India. The United States holds the largest market share owing to the high diagnosis rates of seizure disorders and the easy availability of second- and third-generation anti-epileptic drugs. The growing demand for novel therapies such as immunotherapy and precision medicine also supports the market growth in the region. Moreover, the robust investment in research and development to advance seizure treatments and the presence of a favorable regulatory environment are poised to fuel market expansion in the region.
The key features of the market report comprise patent analysis, grants analysis, clinical trial analysis, funding and investment analysis, and strategic initiatives by the leading key players. The major companies in the market are as follows:
Pfizer is one of the leading players in the market that focuses on the development of novel therapies for seizures and neurological disorders. Pfizer’s Celontin® (Methsuximide Capsules, USP) is indicated for the treatment of absence (petit mal) seizures and works by suppressing the wave activity linked with lapses of consciousness.
Multinational biopharmaceutical company UCB S.A., based in Brussels, Belgium, is focused on research and development, specializing primarily in the discovery of novel medications for epilepsy, Crohn's disease, and Parkinson's disease. One of the company’s key products is BRIVIACT® (brivaracetam) which is prescribed as adjunctive therapy used to treat partial-onset seizures with or without secondary generalization in patients with epilepsy.
Sanofi, headquartered in Paris, France, has a prominent presence in the market and provides a wide range of medications for neurological disorders, including epilepsy and seizures. Sanofi’s Depakine (sodium valproate), a broad-spectrum anti-epileptic drug, is a reference treatment for epilepsy globally.
Swiss multinational pharmaceutical company Novartis AG plays a significant role in the growth of the market. Its popular drug Afinitor DISPERZ (everolimus ) is an FDA-approved adjunctive treatment for tuberous sclerosis complex (TSC)-associated partial-onset seizures patients aged 2 years and above.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include GSK plc, Eisai Co. Ltd., Abbott, Sumitomo Pharmaceutical Co. Ltd., Teva Pharmaceutical Ltd., and Takeda Pharmaceutical Company Limited.
Upto 15% Off
USD
$3299 $2969
$5499 $4949
$6999 $5949
$8199 $6969
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Drug Type |
|
| Breakup by Route of Administration |
|
| Breakup by End User |
|
| Breakup by Distribution Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share